Major depressive disorder (MDD) is one of the leading causes of disability worldwide, and approximately 30% of patients develop treatment-resistant depression (TRD), a condition that does not respond adequately to conventional antidepressant therapies.
PET imaging reveals molecular mechanism behind ketamine’s antidepressant effects
- Post author:admin
- Post published:March 7, 2026
- Post category:uncategorized